| Literature DB >> 27756376 |
Nicola Mackintosh1, Marius Terblanche2,3, Ritesh Maharaj4, Andreas Xyrichis5, Karen Franklin2, Jamie Keddie2, Emily Larkins5, Anna Maslen5, James Skinner5, Samuel Newman2, Joana Hiew De Sousa Magalhaes6, Jane Sandall6.
Abstract
BACKGROUND: Telemedicine applications aim to address variance in clinical outcomes and increase access to specialist expertise. Despite widespread implementation, there is little robust evidence about cost-effectiveness, clinical benefits, and impact on quality and safety of critical care telemedicine. The primary objective was to determine the impact of critical care telemedicine (with clinical decision support available 24/7) on intensive care unit (ICU) and hospital mortality and length of stay in adults and children. The secondary objectives included staff and patient experience, costs, protocol adherence, and adverse events.Entities:
Keywords: Clinical decision support; Critical care; Patient safety; Systematic review; Telemedicine
Mesh:
Year: 2016 PMID: 27756376 PMCID: PMC5070369 DOI: 10.1186/s13643-016-0357-7
Source DB: PubMed Journal: Syst Rev ISSN: 2046-4053
Search strategy
| 1. eICU.mp. | |
| 2. tele-ICU.mp. | |
| 3. tele-intensive care.mp. | |
| 4. telemonitoring.mp | |
| 5. OR/1-5 | |
| 6. Exp critical care/or critical care.mp. | |
| 7. Exp intensive care/ | |
| 8. Exp intensive care units/or intensive care unit$.mp. | |
| 9. Exp Coronary Care Units/or coronary care unit$.mp | |
| 10. coronary care.mp | |
| 11. high dependency.mp | |
| 12. OR/7-12 | |
| 13. 6 and 13 |
Fig. 1PRISMA flow diagram
Characteristics of included studies
| Study | Country | Number of ICUs | Type of hospital | ICU model and staffing | Baseline standards | Existing IT infrastructure | Vendor | Funding source | Design (EPOC criteria) | Sample | Duration | Outcomes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly et al. (2011) | USA | 7 adult ICUs (medical, cardiovascular, and surgical) across 2 campuses | Academic centre | Closed model of care | 1 year prior to intervention: standardisation of best practice in all units (prevention of venous thrombosis, cardiovascular complications, ventilator-associated pneumonia, and stress ulcers) and introduction of ICU daily goals | 1 unit: electronic record system | Philips VISICU (Baltimore, MD), APACHE® (Cerner, Kansas City, MO) with additional components provided by UMass Critical Care | University of Massachusetts | Controlled before-after study (prospective unblinded stepped-wedge design) | 6290 cases: 1529 control subjects, 4761 intervention subjects | Pre-intervention: April 26, 2005–February 7, 2007 | Primary: hospital and ICU mortality |
| Lilly et al. (2014) | USA | 38 hospitals | Non-teaching, teaching, and teaching affiliated with a university or academic centre | Not reported | Not reported | Each ICU implemented similar technical components, including audio and video connections, an ICU-focused medical record, and software for detecting evolving physiologic instability (Koninklijke Philips N.V.) | VISICU, now owned by Koninklijke Philips N.V. | University of Massachusetts | Controlled before-after study (non-randomised, unblinded, pre-/post-design) | 118,990 cases: 11,558 control subjects, 107,432 intervention subjects | Pre-intervention: May 16, 2003–end not reported | Primary: hospital mortality |
TIDieR (Template for Intervention Description and Replication) checklist [39]
| Checklist | Lilly et al. (2011) | Lilly et al. (2014) |
|---|---|---|
| Why: Describe the rationale, theory, or goal of the elements essential to the intervention | Rationale for introduction of telemedicine linked with: | Rationale for introduction of telemedicine linked with: |
| What: Describe the materials and procedures used in delivery of the intervention | Telemedicine technical system included: | Unclear how many sites already had electronic record system in place prior to the start of the programme. Telemedicine technical system provided by Koninklijke Philips N.V. (previously Philips VISICU) which included: |
| Who: Describe the providers of the intervention | Off-site cover | Off-site cover |
| Where: location where the intervention took place | Off-site support centre | Not reported |
| When and how much: Describe the number of times the intervention was delivered and over what period of time including the number of sessions, their schedule, and their duration, intensity, or dose | • Off-site clinicians reviewed care plans for 48 % of after-hours admissions (46 % reviewed by other methods in the control period) | Not reported |
| Tailoring or modifications: If the intervention was planned to be personalised, or was adapted during the course of the study, then describe what, why, when, and how. | Not reported | Not reported |
| How well: assessment of the intervention adherence or fidelity and description of any strategies used to maintain or improve fidelity | Not reported | Not reported |
Effects of intervention
| Mortality | |||
| Lilly et al. (2011) | Hospital mortality | ICU mortality | |
| Pre-intervention ( | 13.6 % | 10.7 % | |
| Telemedicine ( | 11.8 % | 8.6 % | |
| Difference | 1.8 % | 2.1 % | |
| Adjusted odds ratio | OR, 0.40; CI, 0.31–0.52; | OR, 0.37; CI, 0.28–0.49; | |
| Lilly et al. (2014) | Hospital mortality | ICU mortality | |
| Control group ( | 11 % | 8 % | |
| Telemedicine ( | 10 % | 6 % | |
| Difference | 1 % | 2 % | |
| Adjusted hazard ratio | HR, 0.84; CI, 0.78–0.89; | HR, 0.74; CI, 0.68–0.79; | |
| Length of stay | |||
| Lilly et al. (2011) | Hospital length of stay | ICU length of stay | |
| Pre-intervention ( | 13.3 days | 6.4 days | |
| Telemedicine ( | 9.8 days | 4.5 days | |
| Difference | 3.5 days | 1.9 days | |
| Adjusted hazard ratio | HR, 1.44; CI, 1.33–1.56; | HR, 1.26; CI, 1.17–1.36; | |
| Lilly et al. (2014) | Hospital length of stay | ICU length of stay | |
| Control group ( | |||
| Telemedicine ( | |||
| Adjusted LOS difference | 15 % shorter; CI, 14–17 %; | 20 % shorter; CI, 19–22 %; | |
| Adherence to best practice | |||
| Lilly et al. (2011) | DVT prophylaxis | SU prophylaxis | |
| Pre-intervention | 85 % (1299/1527) | 83 % (1253/1505) | |
| Telemedicine | 99 % (4707/4733) | 96 % (4550/4760) | |
| Odds ratio | 15.4; CI, 11.3–21.1; | 4.57; CI, 3.91–5.77; | |
| Lilly et al. (2011) | Cardiovascular protection | VAP prevention | |
| Pre-intervention | 80 % (311/391) | 33 % (190/582) | |
| Telemedicine | 99 % (2866/2894) | 52 % (770/1492) | |
| Odds ratio | 30.7; CI, 19.3–49.2; | 2.20; CI, 1.79–2.70; | |
| Preventable complication rates | |||
| Lilly et al. (2011) | VAP | CRBSI | AKI |
| Pre-intervention | 13 % (76/584) | 1.0 % (19/1529) | 12 % (174/1452) |
| Telemedicine | 1.6 % (32/1949) | 0.6 % (29/4761) | 12 % (540/4565) |
| Odds ratio | 0.15; CI, 0.09–0.23; | 0.50; CI, 0.27–0.93; | 1.00; CI, 0.71–1.69; |
Characteristics of excluded studies
| Study | Reason for exclusion |
|---|---|
| Dhakal et al. [ | Uncontrolled before and after design |
| Gupta et al. [ | Uncontrolled before and after design, single site |
| Kohl et al. [ | Controlled before and after study, only 1 intervention and control site |
| Morrison et al. [ | Interrupted time series (ITS) study with less than 3 data entry points before/after each intervention |
| Nassar et al. [ | Interrupted time series (ITS) study with less than 3 data entry points before/after each intervention |
| Sadaka et al. [ | Uncontrolled before and after design, single site |
| Thomas et al. [ | Uncontrolled before and after design |
| Willmitch et al. [ | Uncontrolled before and after design |
| Zawade et al. [ | Uncontrolled before and after design |